APA (7th ed.) Citation

KV, H., MR, G., M, H., S, N., R, V., EK, S., . . . JE, L. (2022). Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. EClinicalMedicine, 48, 101477. https://doi.org/10.1016/j.eclinm.2022.101477

Chicago Style (17th ed.) Citation

KV, Houser, et al. "Safety and Immunogenicity of an HIV-1 Prefusion-stabilized Envelope Trimer (Trimer 4571) Vaccine in Healthy Adults: A First-in-human Open-label, Randomized, Dose-escalation, Phase 1 Clinical Trial." EClinicalMedicine 48 (2022): 101477. https://doi.org/10.1016/j.eclinm.2022.101477.

MLA (9th ed.) Citation

KV, Houser, et al. "Safety and Immunogenicity of an HIV-1 Prefusion-stabilized Envelope Trimer (Trimer 4571) Vaccine in Healthy Adults: A First-in-human Open-label, Randomized, Dose-escalation, Phase 1 Clinical Trial." EClinicalMedicine, vol. 48, 2022, p. 101477, https://doi.org/10.1016/j.eclinm.2022.101477.